🇺🇸 FDA
Patent

US 6747043

Alkoxy aryl &bgr;2 adrenergic receptor agonists

expired A61PA61P11/00A61P11/06

Quick answer

US patent 6747043 (Alkoxy aryl &bgr;2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P11/00, A61P11/06, A61P15/06, A61P25/00